[与Helicobacter pylori根除疗法相关的因素的综合分析]
概括
治疗时间较长的Helicobacter pylori (HP) 根除,特别是14天的三重或10天的同时治疗,改善了成功率. 克拉里胺素耐药性突变是HP根除失败的最强预测因素.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- Helicobacter pylori (HP) 根除失败是一个重大的临床挑战.
- 之前对HP根除因子的研究表明,患者群体有所变化,这限制了比较风险分析.
- 需要在单个研究群体内进行全面的调查,以澄清风险因素.
研究的目的:
- 调查与成功根除HP相关的因素.
- 为了比较不同根除方案的疗效.
- 为了确定HP根除失败的最强预测因素.
主要方法:
- 554名HP感染的成年患者的回顾性审查.
- 根除治疗的分类根据酸阻断剂类型 (PPI或P-CAB),抗生素组合和持续时间.
- 对人口统计和克拉里素耐药性突变状态的分析.
主要成果:
- 与7天的三重治疗相比,14天的三重治疗和10天的同时治疗显示出更高的根除率.
- 根除率因治疗方案而异:基于泰戈普拉桑的7天三倍 (61.6%),基于泰戈普拉桑的14天三倍 (77.5%),基于拉贝普拉索的14天三倍 (71.1%),基于拉贝普拉索的10天并发 (73.1%),基于泰戈普拉桑的10天并发 (80.5%).
- 克拉里胺抗性突变是根除失败的最强预测因素 (HR 9.86).
结论:
- 14天的三重疗法和10天的同时治疗比7天的三重疗法更有效地消除HP,无论使用的酸阻断剂.
- 克拉里菌素耐药性突变状态是HP根除成功的更重要的预测因素,而不是抗生素选择或治疗持续时间.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
333
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
333
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
97
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
97
01:26Peptic Ulcer Disease IV: Management
75
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
75
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
358
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
358
01:30Peptic Ulcer Disease I: Introduction
144
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
144
01:23Gastritis III: Clinical Manifestations and Management
183
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
183